Press release
Pulmonary Drug Delivery Devices Market 2016 - 2024; Drivers and Restraints Snapshot Analysis
The global market for pulmonary drug devices has gained substantially over the last few years and, with the alarming rise in the air pollution leading to the increased incidence rate of respiratory disorders, it is likely to maintain its growth at a high pace in the years to come. The increasing number of smokers across the world is also adding to the rising pool of the patients suffering from chronic obstructive pulmonary diseases (COPD), consequently benefitting the worldwide pulmonary drug delivery devices market considerably.
Going forward, the market is expected to gain significant momentum over the next few years due to the increasing research and development activities in asthma and COPD treatments. However, various regulatory hurdles and the patent expiry of blockbuster drugs may restrict the growth of this market to some extent in the near future.
Read Full Report: http://www.transparencymarketresearch.com/pulmonary-drug-delivery-systems.html
The global market for pulmonary drug devices presented an opportunity worth US$32.2 bn in 2015. Propagating at a CAGR of 3.30% during the period from 2016 to 2024, the market is likely to attain a value of US$43.05 bn by the end of 2024.
North America and Europe to Continue to Lead Global Pulmonary Drug Delivery Devices Market
Europe, North America, Asia Pacific, Latin America, and the Middle East and Africa are the main regional markets for pulmonary drug delivery devices. Of these, North America has acquired the top position and is followed closely by Europe. The increasing prevalence of COPD is the key factor behind the growth of these regional markets. Analysts expect both the markets to retain their position over the forthcoming years, thanks to the technological advancements in pulmonary drug delivery devices. The U.S. and Canada have surfaced as the key domestic markets in North America, whereas, the Europe market for pulmonary drug delivery devices is led by Germany.
On the other hand, the pulmonary drug delivery devices market in Asia Pacific, Latin America, and the Middle East and Africa are likely to present great opportunities to manufacturers in the near future due to the high incidence rate of respiratory disorders. The growing awareness among consumers and their increasing disposable income are also projected to drive these markets over the next few years.
Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=873
Demand for Pulmonary Drug Delivery Devices to Remain High among Asthma Patients
Pulmonary drug delivery devices find a widespread application in the treatment of asthma, COPD, and cystic fibrosis. Among these, the demand from the asthma segment is much higher than others and is likely to remain so over the next few years, thanks to the robust pipeline of drugs for the treatment of asthma.
Some the key players operating in the global market for pulmonary drug delivery devices are Boehringer Ingelheim GmbH, Novartis AG, GlaxoSmithKline Plc, AstraZeneca Plc, Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., MannKind Corp., Bristol-Myers Squibb Co., Mylan N.V., Omron Corp., F. Hoffmann-La Roche Ltd., 3M Healthcare, Sunovion Pharmaceuticals Inc., Koninklijke Philips N.V., Gerresheimer AG, Bespak, AptarGroup Inc., SHL Group, Nypro Healthcare Inc., Hovione, and Chiesi Farmaceutici S.p.A.
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pulmonary Drug Delivery Devices Market 2016 - 2024; Drivers and Restraints Snapshot Analysis here
News-ID: 455266 • Views: …
More Releases from TMR - Research Reports
Visualization and 3D Rendering Software Market: On-Premise Deployment Presently …
The global market for visualization and 3D rendering features a largely consolidated vendor landscape, with the leading three vendors accounting for a nearly 80% of the overall revenue generated in the market in 2016, observes Transparency Market Research in a recent report. These three vendors, namely Autodesk Inc., Dassault Systems, and NVIDIA Corporation, have strengthened their positions in the market with the help of cost competitive pricing, continuous introduction of…
Digital Door Lock Systems Market: Enhanced Security Requirements to Propel the D …
According to a new market report published by Transparency Market Research titled “Digital Door Lock Systems Market–Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026,” the global digital door lock systems market was valued at US$ 1,059.5 Mn in 2017 and is expected to expand at a CAGR of 30.25% from 2018 to 2026, reaching US$ 14,877.6 Mn by the end of the forecast period.
digital door lock systems market…
Transportation Management System Market: Advance Technologies in All the Sectors …
A transportation management system (TMS) refers to a subset of supply chain management and is centered mostly on logistics and transportation. The augmented use of cloud computing technologies for managing supply chain activities is one of the significant and major trends that have been prevailing in the world market for transportation management systems. Cloud-based deployments, in general, need less configuration and customization. These two factors are triggering down the cost…
Energy Recovery Ventilators Market: Rising Awareness of Importance of Indoor Air …
Characterized by the presence of a handful of dominant players, namely United Technologies Corp., LG Electronics, Daikin Industries Ltd., Fujitsu Ltd., and Munters Corp., the global energy recovery ventilators market features intense competition, reveals Transparency Market Research (TMR) in a new report.
Going forward, the rising number of players seeking entry will further intensify competition in the market. Expansion of product portfolio which has been the focus of established companies to…
More Releases for Pulmonary
Chronic Pulmonary Aspergillosis Drugs Market - Revitalizing Lungs: Revolutionary …
Newark, New Castle, USA - new report, titled Chronic Pulmonary Aspergillosis Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Pulmonary Aspergillosis Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Pulmonary Aspergillosis Drugs market. The report offers…
Global Pulmonary Embolism Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Pulmonary Embolism Market is exhibited at USD 1.59 billion in 2023 and is projected to surpass USD 3.15 billion in 2028, anticipated to grow at a CAGR of 8.4% from 2023 to 2028.
The rapid increase in the prevalence of cancer, increasing investment for healthcare infrastructure and rising research and development activities, high disposable income, rising demand…
Global Pulmonary Arterial Hypertension Market Size
According to a new market research report published by Global Market Estimates, the Global Pulmonary Arterial Hypertension Market is projected to grow at a CAGR of 5.2% from 2022 to 2027.
Congenital heart diseases and other ailments such as HIV infection, chronic liver disease (cirrhosis), and connective tissue disorders (scleroderma, lupus, and others) are fueling market expansion.
Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC…
New Study: Pulmonary Drugs Market Report
The pulmonary drugs market is expected to witness unprecedented growth in the near future, thanks to large number of approvals from the FDA. The FDA approved a large number of pulmonary drugs for major illnesses like small-cell lung cancer, tuberculosis, and pneumonia over the past few years. Additionally, newly approved drugs also treat newly found diseases like obstructive sleep apnea. These approvals are in line with the recent trend of…
Pulmonary Drugs Market Forecast till 2025
Pulmonary Drugs Market – Boon for Diseased Lungs
Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treated…
Pulmonary Drug Delivery Devices Market: Demand for Pulmonary Drug Delivery Devic …
This report on pulmonary drug delivery devices studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pulmonary/respiratory drugs and/or drug-device combinations as well as new entrants planning to enter this market.
This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments…
